OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) insider Jeffrey Yu acquired 1,666,666 shares of the firm’s stock in a transaction dated Friday, June 20th. The shares were purchased at an average cost of $0.42 per share, for a total transaction of $699,999.72. Following the acquisition, the insider directly owned 6,737,410 shares in the company, valued at $2,829,712.20. This represents a 32.87% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Jeffrey Yu also recently made the following trade(s):
- On Thursday, September 25th, Jeffrey Yu bought 1,250 shares of OneMedNet stock. The stock was purchased at an average price of $1.03 per share, with a total value of $1,287.50.
- On Wednesday, September 24th, Jeffrey Yu bought 17,200 shares of OneMedNet stock. The stock was purchased at an average cost of $1.02 per share, with a total value of $17,544.00.
- On Tuesday, September 23rd, Jeffrey Yu purchased 5,700 shares of OneMedNet stock. The shares were acquired at an average price of $0.93 per share, for a total transaction of $5,301.00.
- On Monday, September 22nd, Jeffrey Yu purchased 400 shares of OneMedNet stock. The stock was acquired at an average cost of $0.95 per share, for a total transaction of $380.00.
- On Friday, September 19th, Jeffrey Yu acquired 1,250 shares of OneMedNet stock. The stock was acquired at an average price of $0.89 per share, with a total value of $1,112.50.
- On Thursday, September 18th, Jeffrey Yu acquired 700 shares of OneMedNet stock. The stock was acquired at an average price of $0.91 per share, with a total value of $637.00.
- On Friday, September 5th, Jeffrey Yu bought 2,100 shares of OneMedNet stock. The shares were acquired at an average price of $0.86 per share, for a total transaction of $1,806.00.
- On Thursday, September 4th, Jeffrey Yu bought 11,810 shares of OneMedNet stock. The stock was acquired at an average cost of $0.87 per share, for a total transaction of $10,274.70.
- On Wednesday, September 3rd, Jeffrey Yu purchased 11,670 shares of OneMedNet stock. The stock was acquired at an average cost of $0.81 per share, with a total value of $9,452.70.
- On Tuesday, September 2nd, Jeffrey Yu purchased 24,319 shares of OneMedNet stock. The shares were acquired at an average price of $0.85 per share, with a total value of $20,671.15.
OneMedNet Trading Up 20.8%
NASDAQ ONMD opened at $1.72 on Monday. OneMedNet Corporation has a 1-year low of $0.30 and a 1-year high of $4.22. The company has a market capitalization of $87.48 million, a price-to-earnings ratio of -34.30 and a beta of 1.10. The stock’s 50 day moving average is $1.80 and its two-hundred day moving average is $1.01.
Analysts Set New Price Targets
Several equities research analysts have recently commented on the stock. Wall Street Zen upgraded shares of OneMedNet to a “hold” rating in a research note on Friday, September 26th. Weiss Ratings reissued a “sell (d-)” rating on shares of OneMedNet in a report on Tuesday, October 14th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.
Check Out Our Latest Report on OneMedNet
Hedge Funds Weigh In On OneMedNet
A number of institutional investors and hedge funds have recently bought and sold shares of ONMD. Correct Capital Wealth Management acquired a new stake in shares of OneMedNet in the third quarter valued at $4,910,000. Exencial Wealth Advisors LLC grew its holdings in OneMedNet by 141.3% during the 3rd quarter. Exencial Wealth Advisors LLC now owns 3,599,460 shares of the company’s stock worth $3,923,000 after acquiring an additional 2,107,598 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC bought a new stake in OneMedNet during the 3rd quarter worth about $25,000. Institutional investors and hedge funds own 0.95% of the company’s stock.
OneMedNet Company Profile
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.
Featured Stories
- Five stocks we like better than OneMedNet
- 3 Warren Buffett Stocks to Buy Now
- Worried About Inflation? These 3 ETFs Offer Real Protection
- Growth Stocks: What They Are, Examples and How to Invest
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
- 5 discounted opportunities for dividend growth investors
- Klarna’s Crypto Play: A Plan to Fix Its Profit Problem
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
